Dublin's Jazz buys Italy firm for US1bn

Dublin-based Jazz Pharmaceuticals said it would buy Italian biotech company Gentium S.p.A. for about $1 billion to get access to its lead product candidate, Defitelio, a drug used for the treatment of a rare liver condition.

http://www.businessworld.ie/livenews.htm?a=3126765